Anika Therapeutics Ownership | Who Owns Anika Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Anika Therapeutics Ownership Summary


Anika Therapeutics is owned by 11.52% institutional investors, 4.88% insiders, and 83.59% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 11.52% of ANIK shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.10% of its assets in Anika Therapeutics shares.

ANIK Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAnika Therapeutics11.52%4.88%83.59%
SectorHealthcare Stocks 232.64%10.66%-143.30%
IndustryMedical Device Stocks37.54%10.61%51.85%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de1.65M11.52%$15.90M
Trigran investments1.62M11.31%$15.24M
Blackrock1.61M10.93%$40.70M
Caligan partners lp1.44M10.01%$13.49M
Vanguard group779.16K5.43%$7.49M
Morgan stanley772.23K5.38%$7.42M
Acadian asset management606.54K4.22%$5.82M
Boothbay fund management539.64K3.77%$5.07M
Renaissance515.72K3.59%$4.96M
Capital management corp /va500.46K3.48%$4.81M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Trigran investments1.62M2.76%$15.24M
Caligan partners lp1.44M1.77%$13.49M
Cove street capital101.96K1.25%$958.39K
Capital management corp /va500.46K0.79%$4.81M
Diker management56.84K0.43%$534.29K
Ironwood investment management65.61K0.27%$630.51K
Pharvision advisers41.39K0.22%$389.03K
R squared41.58K0.19%$399.59K
Objectivity squared31.57K0.17%$303.44K
Virtus fund advisers2.72K0.14%$44.84K

Top Buyers

HolderShares% AssetsChange
Morgan stanley772.23K0.00%377.49K
Goldman sachs group164.93K0.00%99.95K
Jane street group134.77K0.00%85.03K
Gsa capital partners llp122.06K0.10%80.32K
Two sigma investments, lp79.92K0.00%79.92K

Top Sellers

HolderShares% AssetsChange
Opaleye management---588.80K
Alta fundamental advisers---454.94K
Trigran investments1.62M2.76%-415.30K
Stonepine capital management---190.59K
Meros investment management, lp---173.49K

New Positions

HolderShares% AssetsChangeValue
Two sigma investments, lp79.92K0.00%79.92K$751.26K
Trexquant investment lp44.69K0.00%44.69K$420.10K
Pharvision advisers41.39K0.22%41.39K$389.03K
Cubist systematic strategies37.45K0.00%37.45K$352.00K
Objectivity squared31.57K0.17%31.57K$303.44K

Sold Out

HolderChange
Assetmark-3.00
Nelson, van denburg & campbell wealth management group-3.00
Hexagon capital partners-8.00
Ronald blue trust-24.00
Covestor-24.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202524-78.95%1,655,041-86.47%110.16%11-84.06%9-65.38%
Sep 30, 202539-61.39%1,942,121-84.69%130.17%25-54.55%8-74.19%
Jun 30, 2025101-6.48%12,685,0363.92%881.21%5412.50%31-24.39%
Mar 31, 2025109-1.80%12,677,8191.18%881.23%48-11.11%427.69%
Dec 31, 2024110-10.57%12,521,428-4.37%841.08%538.16%39-18.75%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF439.41K3.10%-
Vanguard Total Stock Mkt Idx Inv428.62K2.97%-
CMC SMID289.47K2.01%-58.73K
iShares Russell 2000 ETF280.95K1.95%-30.77K
CMC All-Cap Growth170.05K1.18%170.05K
Vanguard Institutional Extnd Mkt Idx Tr164.18K1.14%-
BlackRock Credit Strategies Instl132.11K0.92%75.46K
Fidelity Small Cap Index128.23K0.89%-152.00
Franklin Mutual Small-Mid Cap Val A120.97K0.83%-
iShares Russell 2000 Value ETF104.25K0.72%-38.08K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q3--

ANIK Ownership FAQ


Who Owns Anika Therapeutics?

Anika Therapeutics shareholders are primarily institutional investors at 11.52%, followed by 4.88% insiders and 83.60% retail investors. The average institutional ownership in Anika Therapeutics's industry, Medical Device Stocks, is 37.54%, which Anika Therapeutics falls below.

Who owns the most shares of Anika Therapeutics?

Anika Therapeutics’s largest shareholders are Blackrock funding, inc. /de (1.65M shares, 11.52%), Trigran investments (1.62M shares, 11.31%), and Blackrock (1.61M shares, 10.93%). Together, they hold 33.77% of Anika Therapeutics’s total shares outstanding.

Does Blackrock own Anika Therapeutics?

Yes, BlackRock owns 10.93% of Anika Therapeutics, totaling 1.61M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 40.7M$. In the last quarter, BlackRock increased its holdings by 45.79K shares, a 2.93% change.

Who is Anika Therapeutics’s biggest shareholder by percentage of total assets invested?

Trigran investments is Anika Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.76% of its assets in 1.62M Anika Therapeutics shares, valued at 15.24M$.

Who is the top mutual fund holder of Anika Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Anika Therapeutics shares, with 3.10% of its total shares outstanding invested in 439.41K Anika Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools